MindMaze Therapeutics Holding SA (SWX: MMTX)
Health Care · Biotechnology · CH
CHF0.17
-27.16% today · -87.9% 1Y
MindMaze Therapeutics Holding SA (SWX: MMTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $43.06M and employs 10 people.
Over the last twelve months the share price has lost 87.9%, trading between 0.15 and 2.92.
MMTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $43.06M
- Revenue (TTM)
- $809.63K
- P/E
- —
- EPS
- -0.48
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- CHF2.92
- 52-week low
- CHF0.15
- Avg volume (3M)
- —
- Shares outstanding
- 152.60M
- Employees
- 10
- Next earnings
- —
About MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA creates and manages the MindMaze platform, which combines neuroscience with digital therapeutics to confront critical challenges in the field of neurology. Established in 2025, this company, headquartered in Lausanne, Switzerland, was previously named NeuroX Group SA.
- ISIN
- CH1251125998
- Founded
- 2012
- Listed since
- Dec 15, 2025
- Exchange
- SIX Swiss Exchange
- Currency
- CHF
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €864.20 | -4.19% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $138.89 | -4.26% |
Figures last refreshed Aug 18, 2026.